The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection:a prospective multicenter study

Journal of Clinical Gastroenterology

Volumn 46, Issue 1, 2012, Pages 51-56

  Kim, You Sun ^a   Kim, Young Ho ^b   Kim, Joo Sung ^c   Cheon, Jae Hee ^d   Ye, Byong Duk ^e   Jung, J Sung Ae ^f   Park, Young Sook ^g   Choi, Chang Hwan ^h   Jang, Byung Ik ^j   Han, Dong Soo ⁱ   Yang, Suk Kyun ^e   Kim, Won Ho ^d  

^a Inje University   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University   (South Korea)

^d Yonsei University   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

^f Ewha Womans University School of Medicine   (South Korea)

^g Eulji University   (South Korea)

^h Chung Ang University   (South Korea)

ⁱ Hanyang University   (South Korea)

^j Yeungnam University College of Medicine   (South Korea)

more..

Author keywords

Cytomegalovirus; Ganciclovir; Steroids; Ulcerative colitis

Indexed keywords

CYCLOSPORIN A; GANCICLOVIR; HYDROCORTISONE; INFLIXIMAB; STEROID;

ANTIVIRAL THERAPY; ARTICLE; CLINICAL PROTOCOL; COLON RESECTION; COLONOSCOPY; CYTOMEGALOVIRUS INFECTION; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; SIGMOIDOSCOPY; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

ADULT; ANTIVIRAL AGENTS; COLITIS, ULCERATIVE; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE; FEMALE; GANCICLOVIR; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84856438823     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3182160c9c     Document Type: Article

References (18)

1. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med. 1993;119:924-935.
2. Rowshani AT, Bemelman FJ, van Leeuwen EM, et al. Clinical and immunologic aspects of cytomegalovirus infection in solid organ transplant recipients. Transplantation. 2005;79:381-386.
3. Griffiths PD. The 2001 Garrod lecture. The treatment of cytomegalovirus infection. J Antimicrob Chemother. 2002;49:243-253.
4. Wada Y, Matsui T, Matake H, et al. Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum. 2003;46:S59-S65.
5. Domenech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008;14:1373-1379.
6. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001;96:773-775.
7. Criscuoli V, Casa A, Orlando A, et al. Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis. 2004;36:818-820.
8. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis? A randomized study. N Engl J Med. 1987;317:1625-1629.
9. Creed TJ, Probert CS, Norman MN, et al. Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease. Aliment Pharmacol Ther. 2006;23:1435-1442.
10. Baron JH, Connell AM, Lennard-Jones JE. Variation between observers in describing mucosal appearances in proctocolitis. Br Med J. 1964;1:89-92.
11. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094-1097.
12. Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53:1155-1160.
13. Vega R, Bertran X, Menacho M, et al. Cytomegalovirus infection in patients with inflammatory bowel disease. Am J Gastroenterol. 1999;94:1053-1056.
14. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96:2137-2142.
15. Matsuoka K, Iwao Y, Mori T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007;102:331-337.
16. Dimitroulia E, Spanakis N, Konstantinidou AE, et al. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:879-884.
17. Minami M, Ohta M, Ohkura T, et al. Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. World J Gastroenterol. 2007;13:754-760.
18. Ayre K, Warren BF, Jeffery K, et al. The role of CMV in steroid-resistant ulcerative colitis: a systematic review. J Crohn's Colitis. 2009;3:141-148.